The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection

TL Katzenstein; O Kirk; C Pedersen; Jens Dilling Lundgren; H Nielsen; N Obel; C Nielsen; Lars Reinhardt Mathiesen; J Gerstoft

doi:http://dx.doi.org/10.1086/315746

The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection

TL Katzenstein, O Kirk, C Pedersen, Jens Dilling Lundgren, H Nielsen, N Obel, C Nielsen, Lars Reinhardt Mathiesen, J Gerstoft

25 Citations (Scopus)

Abstract

The Danish Protease Inhibitor (PI) Study has enrolled 318 human immunodeficiency virus (HIV)-infected, PI-naive patients for the purpose of comparing 3 PI-containing regimens for the treatment of HIV infection. The regimens include 2 nucleoside analogues in combination with indinavir (Idr), ritonavir (Rtv), or Rtv and saquinavir (Rtv/Sqv). Similar percentages of patients in the 3 study arms achieved reduced levels (

Original language	English
Journal	Journal of Infectious Diseases
Volume	182
Issue number	3
Pages (from-to)	744-50
Number of pages	6
ISSN	0022-1899
DOIs	https://doi.org/10.1086/315746
Publication status	Published - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://dx.doi.org/10.1086/315746

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10950767

Cite this

Katzenstein, TL., Kirk, O., Pedersen, C., Lundgren, J. D., Nielsen, H., Obel, N., Nielsen, C., Mathiesen, L. R., & Gerstoft, J. (2000). The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection. Journal of Infectious Diseases, 182(3), 744-50. https://doi.org/10.1086/315746

The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection. / Katzenstein, TL; Kirk, O; Pedersen, C et al.

In: Journal of Infectious Diseases, Vol. 182, No. 3, 2000, p. 744-50.

Research output: Contribution to journal › Journal article › Research › peer-review

Katzenstein, TL, Kirk, O, Pedersen, C, Lundgren, JD, Nielsen, H, Obel, N, Nielsen, C, Mathiesen, LR & Gerstoft, J 2000, 'The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection', Journal of Infectious Diseases, vol. 182, no. 3, pp. 744-50. https://doi.org/10.1086/315746

@article{fea0a3f2e9494b1d8a6dc40cf0fb1dc7,

title = "The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection",

abstract = "The Danish Protease Inhibitor (PI) Study has enrolled 318 human immunodeficiency virus (HIV)-infected, PI-naive patients for the purpose of comparing 3 PI-containing regimens for the treatment of HIV infection. The regimens include 2 nucleoside analogues in combination with indinavir (Idr), ritonavir (Rtv), or Rtv and saquinavir (Rtv/Sqv). Similar percentages of patients in the 3 study arms achieved reduced levels (",

author = "TL Katzenstein and O Kirk and C Pedersen and Lundgren, {Jens Dilling} and H Nielsen and N Obel and C Nielsen and Mathiesen, {Lars Reinhardt} and J Gerstoft",

year = "2000",

doi = "http://dx.doi.org/10.1086/315746",

language = "English",

volume = "182",

pages = "744--50",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection

AU - Katzenstein, TL

AU - Kirk, O

AU - Pedersen, C

AU - Lundgren, Jens Dilling

AU - Nielsen, H

AU - Obel, N

AU - Nielsen, C

AU - Mathiesen, Lars Reinhardt

AU - Gerstoft, J

PY - 2000

Y1 - 2000

N2 - The Danish Protease Inhibitor (PI) Study has enrolled 318 human immunodeficiency virus (HIV)-infected, PI-naive patients for the purpose of comparing 3 PI-containing regimens for the treatment of HIV infection. The regimens include 2 nucleoside analogues in combination with indinavir (Idr), ritonavir (Rtv), or Rtv and saquinavir (Rtv/Sqv). Similar percentages of patients in the 3 study arms achieved reduced levels (

AB - The Danish Protease Inhibitor (PI) Study has enrolled 318 human immunodeficiency virus (HIV)-infected, PI-naive patients for the purpose of comparing 3 PI-containing regimens for the treatment of HIV infection. The regimens include 2 nucleoside analogues in combination with indinavir (Idr), ritonavir (Rtv), or Rtv and saquinavir (Rtv/Sqv). Similar percentages of patients in the 3 study arms achieved reduced levels (

U2 - http://dx.doi.org/10.1086/315746

DO - http://dx.doi.org/10.1086/315746

M3 - Journal article

SN - 0022-1899

VL - 182

SP - 744

EP - 750

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 3

ER -

The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this